Testing for a gene commonly mutated in ovarian cancers could pick out patients who will respond well to a promising new class of cancer drugs, a major new study reveals.

Researchers have made a major discovery about how cells control when to divide – representing a step forward in scientists’ understanding of one of the most fundamental processes of life.

Scientists have developed an easy-to-use software tool that can detect important genetic mutations that previously needed to be identified by a separate test.